TuHURA Posts Initial IFx-2.0 Data in Merkel Cell Carcinoma Study
TuHURA reported initial data from the first three patients in an open-label Phase 1b/2a study of IFx-2.0 with Keytruda in metastatic Merkel cell carcinoma.
TuHURA reported initial data from the first three patients in an open-label Phase 1b/2a study of IFx-2.0 with Keytruda in metastatic Merkel cell carcinoma.